BEVACIZIMAB

Clinical trials for BEVACIZIMAB explained in plain language.

Never miss a new study

Get alerted when new BEVACIZIMAB trials appear

Sign up with your email to follow new studies for BEVACIZIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New combo therapy targets hard-to-treat colon cancer

Disease control Not yet recruiting

This early-phase study tests whether adding the experimental drug SAR445877 to standard chemotherapy (FOLFOX6) and a targeted therapy (bevacizumab) is safe for people with a specific type of advanced colorectal cancer called microsatellite stable (MSS). The study will include abo…

Matched conditions: BEVACIZIMAB

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 12, 2026 13:43 UTC

BEVACIZIMAB

Get alerted when new BEVACIZIMAB trials appear

New combo therapy targets hard-to-treat colon cancer